CS logo
small CS logo
S.C. Diabmed Dr. Popescu Alexandrina S.R.L

Ploiesti, Romania
Doctor in Ploiești
Strada Transilvaniei 20, Ploiești 100179

About S.C. Diabmed Dr. Popescu Alexandrina S.R.L


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Pfizer
2
Boehringer Ingelheim
1
Kowa Research Institute, Inc.
1
Total Rows: 4

Clinical Trials at S.C. Diabmed Dr. Popescu Alexandrina S.R.L


During the past decade, S.C. Diabmed Dr. Popescu Alexandrina S.R.L conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111100220011002211110000Started TrialsCompleted Trails2017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
2018-04-05
2019-10-10
Completed
1,842
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
2020-10-19
2022-11-01
Completed
1,428
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
2022-08-01
2027-06-07
Recruiting
780

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "S.C. Diabmed Dr. Popescu Alexandrina S.R.L" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 4Eli Lilly and Company: 4Pfizer: 2Pfizer: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Kowa Research Institute, Inc.: 1Kowa Research Institute, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBrigham and Women'sHospital: 1Brigham and Women'sHospital: 1Eli Lilly and Company: 1Eli Lilly and Company: 1

Clinical Trials Conditions at S.C. Diabmed Dr. Popescu Alexandrina S.R.L


According to Clinical.Site data, the most researched conditions in "S.C. Diabmed Dr. Popescu Alexandrina S.R.L" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes" (2 trials), "Dyslipidemia" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "S.C. Diabmed Dr. Popescu Alexandrina S.R.L" in a lesser frequency.

Clinical Trials Intervention Types at S.C. Diabmed Dr. Popescu Alexandrina S.R.L


Most popular intervention types in "S.C. Diabmed Dr. Popescu Alexandrina S.R.L" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Tirzepatide" (3 trials), "Dulaglutide" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Antihyperglycemic medication" (1 trials). Other intervention names were less common.

Clinical Trials Genders at S.C. Diabmed Dr. Popescu Alexandrina S.R.L


The vast majority of trials in "S.C. Diabmed Dr. Popescu Alexandrina S.R.L" are 8 trials for "All" genders.

Clinical Trials Status at S.C. Diabmed Dr. Popescu Alexandrina S.R.L


Currently, there are NaN active trials in "S.C. Diabmed Dr. Popescu Alexandrina S.R.L". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in S.C. Diabmed Dr. Popescu Alexandrina S.R.L, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in S.C. Diabmed Dr. Popescu Alexandrina S.R.L, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Terminated: 3Terminated: 3Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1